IFNG and neoplasm: LIVP-GFP injection resulted in a ten-fold increase of virus-specific IFN-γ-secreting cells in both B-16 and RLS-40 tumour-bearing mice, thus, indicating the stimulation of a T-cell immune response (Fig. 7a).